2Paul F. Lindholm,Jeffrey Bub,Sushma Kaul,Vinod B. Shidham,André Kajdacsy-Balla. The role of constitutive NF-κB activity in PC-3 human prostate cancer cell invasive behavior[J] 2000,Clinical and Experimental Metastasis(6):471～479
4Danica L Rowe, Tuba Ozbay, Ruth M O'Regan, et al. Modulation of the BRCA1 protein and induction of apoptosis in triple negative breast cancer cell lines by the polyphenolic compound curcumin [ J ]. Breast Cancer,2009,3 : 61 - 75.
5Randrianarison V, Marot D, Foray N, et al. BRCA1 carries tumor suppressor activity distinct from that of p53 and p21 [ J]. Cancer Gene Ther, 2001,8 ( 10 ) :759 - 770.
6Horiuchi A, Wang C, Kikuchi N,et al. BRCA1 Expression is an important biomarker for chemosensitivity: suppression of BRCA1 increases the apoptosis via Up - regulation of p53 and p21 during cisplatin treatment in ovarian cancer ceils [ J ]. Biomark Insights, 2007, 1:49 -59.
7Leunen K, Cadron I, Van Gorp T, et al. Does paclitaxel - carbo- platin chemotherapy in a dose - dense regimen enhance survival of BRCA - related ovarian cancer patients[ J ] ? Int J Gynecol Canc- er, 2009,19(9) :1501 - 1504 .
8Quinn JE, James CR, Stewart GE,et al. BRCA1 mRNA expres- sion levels predict for overall survival in ovarian cancer after chemotherapy [ J ]. Clin Cancer Res, 2007, 13 ( 24 ) : 7413 - 7420.
9Weir NM, Selvendiran K, Kutala VK. Curcumin induces G2/M arrest and apoptosis in cisplatin - resistant human ovarian cancer ceils by modulating Akt and p38 MAPK [ J ]. Cancer Biol Ther, 2007, 6(2) :178 - 184.
10Somasundaram K, Zhang H, Zeng YX, et al. Arrest of the cell cy- cle by the tumour - suppressor BRCA1 requires the CDK - inhibi- tor p21WAF1/CiP1 [ J]. Nature, 1997,389 (6647) : 187 - 190.
